No Survival Gain From High-Dose Cytarabine Consolidation in AML No Survival Gain From High-Dose Cytarabine Consolidation in AML

The real-world registry data backup findings from randomized trials comparing high vs intermediate doses. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news